Primrose Bio emerges as biotech powerhouse, secures $15m from Ligand Pharmaceuticals
Primrose Bio, Inc. has been founded as a merger between Primordial Genetics, Inc. and Pelican Technology Holdings, Inc in a transformative move that sets the stage for groundbreaking advancements in biotechnology. The newly-formed private biotechnology company has also received a substantial $15 million funding contribution from Ligand Pharmaceuticals. Primrose Bio aims to revolutionize the discovery […]